BIIB Financial Facts

Fair value adjustment of contingent consideration: 3.63M
Diluted earnings per share attributable to Biogen Idec Inc.: -480.84M
See Full Income Statement

Accrued expenses and other: 979.95M
Total current assets: 3.24B
See Full Balance Sheet

Earnings History for Biogen Idec Inc. (BIIB)

  |   Expand Research on BIIB
Next EPS Date 7/23/13 *Est. EPS Growth Rate +40.7% *Last Qtr.
Average EPS % Beat Rate +13.4% Revenue Growth Rate +8.5% *Last Qtr.
Average % Move 1-Wk after EPS +3.7%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/1/12 Q112 $1.40$1.48 -$0.08$1.29B$1.31B N/A / N/A = +74.6% Details
1/28/13 Q412 $1.40$1.46 -$0.06$1.4B$1.38B N/A / N/A = +60% Details
7/26/11 Q211 $1.36$1.37 -$0.01$1.21B$1.18B N/A / N/A = +125% Details
1/31/12 Q411 $1.51$1.49 +$0.02$1.3B$1.29B N/A / N/A = +100.7% Details
4/21/11 Q111 $1.43$1.41 +$0.02$1.2M$1.18B N/A / N/A = +170.2% Details
10/28/11 Q311 $1.61$1.53 +$0.08$1.31B$1.27B $1.42 / $1.32B = +98.7% Details
10/26/10 Q310 $1.35$1.23 +$0.12N/AN/A N/A / N/A N/A +290.5% Details
2/1/11 Q410 $1.42$1.23 +$0.19$1.22B$1.17B N/A / N/A = +257.3% Details
Like BIIB Earnings? Also take a look at ELN, BMY, AMGN, ABT

BIIB Earnings News